cancer vaccine for breast cancer

Release time ：Dec-21,2024

Breast cancer vaccines represent a novel therapeutic approach designed to prevent or treat breast cancer. They function by stimulating the patient's immune system to identify and combat breast cancer cells, thereby controlling tumor growth. The development of these vaccines is grounded in profound insights into tumor immunology and the detection of specific antigens on the surface of breast cancer cells.

Clinical trials have demonstrated some efficacy of breast cancer vaccines, particularly among patients with HER2-positive breast cancer. These vaccines typically target the specific tumor-associated antigen HER2, eliciting an immune response by administering vaccines that contain HER2 antigens. Additionally, there are vaccines that target other breast cancer-related antigens, such as MUC1 and EGFR. The development and application of these vaccines offer innovative pathways for breast cancer management.

For individuals with breast cancer, vaccine therapy should be undertaken under the supervision of a qualified physician. Prior to initiating vaccine therapy, patients should gain a comprehensive understanding of the associated risks and benefits and adhere to the physician's recommendations. Moreover, patients are advised to maintain healthy lifestyle practices, including a balanced diet and regular exercise, to bolster their immune system and better navigate the challenges encountered during treatment.